Advertisement

Topics

MetrioPharm Announces Positive Top-Line Results from a Phase IIa Study in Moderate-to-Severe Psoriasis with its Oral Lead Compound MP1032

06:05 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Based on these positive results, MetrioPharm plans to move its MP1032 program forward into a phase IIb study in moderate-to-severe psoriasis. MetrioPharm AG, a biotech company developing small molecule immune modulators for ...

Other Sources for this Article

MetrioPharm AG
Eva Brysch
Manager Investor Relations & Corporate Communications
Tel: +49 (0)30 33 84 395 40
Email: eva.brysch@metriopharm.com
or
MetrioPharm Deutschland GmbH
T +49 (0) 30 33 84 395 40
F +49 (0) 30 33 84 395 99
E invest@metriopharm.com
W www.metriopharm.com

NEXT ARTICLE

More From BioPortfolio on "MetrioPharm Announces Positive Top-Line Results from a Phase IIa Study in Moderate-to-Severe Psoriasis with its Oral Lead Compound MP1032"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...